| Ex-Date | Pay Date | Amount | Change |
|---|---|---|---|
| ₩300 | 0% | ||
| ₩300 | 0% | ||
| ₩300 | -14.29% | ||
| ₩300 | -14.29% | ||
| ₩350 | 80.25% | ||
| ₩194.1748 | 31.25% | ||
| ₩147.9427 | |||
| ₩215.82 | 3% | ||
| ₩209.53 | 33.9% | ||
| ₩156.48 | 40% | ||
| ₩111.77 | 109.98% | ||
| ₩53.23 | 65% | ||
| ₩32.26 | 0% | ||
Daewon Pharmaceutical Co Ltd pays a dividend yield (FWD) of 2.25%.
- ISIN
- WKN
- -
- Symbol / Exchange
- / XKRX
- Value
- €8.23
- Dividend frequency
- annually
- Security Type
- Equity
- Sector
Health Care
- Country
South Korea
- Dividend Currency
- South Korean Won
- Earnings Date
- Within the last 12 months, Daewon Pharmaceutical Co Ltd paid a dividend of ₩300. For the next 12 months, Daewon Pharmaceutical Co Ltd is expected to pay a dividend of ₩300. This corresponds to a dividend yield of approximately 2.25%.
- The dividend yield of Daewon Pharmaceutical Co Ltd is currently 2.25%.
- Daewon Pharmaceutical Co Ltd pays annually dividends. Payout is in April.
- The next dividend will be paid on 25 April 2025.
- Within the last 10 years, Daewon Pharmaceutical Co Ltd has paid dividends in 8 of them.
- Dividends of ₩300 are expected for the next 12 months. This corresponds to a dividend yield of 2.25%.
- Daewon Pharmaceutical Co Ltd is assigned to the sector "Health Care".
- The last stock split of Daewon Pharmaceutical Co Ltd was on 24 December 2007 in the ratio 2:1.
- In order to receive the future dividend from Daewon Pharmaceutical Co Ltd on 25 April 2025 you must have purchased your Daewon Pharmaceutical Co Ltd shares before the ex-date on 27 December 2024.
- To receive the last dividend of Daewon Pharmaceutical Co Ltd on 19 April 2024 in the amount of ₩300 you had to have the stock in your portfolio before the ex-day on 27 December 2023.
- The last dividend was paid on 19 April 2024.
- In 2022, dividends of ₩194 were paid by Daewon Pharmaceutical Co Ltd.
- Dividends from Daewon Pharmaceutical Co Ltd are paid in South Korean Won.
- The headquarters of Daewon Pharmaceutical Co Ltd is located in South Korea.